Prospective investigation of serum anti-Müllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Prospective investigation of serum anti-Müllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study. / Freiesleben, N la Cour; Rosendahl, Mikkel; Johannsen, Trine Holm; Løssl, Kristine; Loft, A; Bangsbøll, S; Friis-Hansen, L; Pinborg, Anja Bisgaard; Andersen, A Nyboe.

In: Reproductive BioMedicine Online, Vol. 20, No. 5, 01.05.2010, p. 582-7.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Freiesleben, NLC, Rosendahl, M, Johannsen, TH, Løssl, K, Loft, A, Bangsbøll, S, Friis-Hansen, L, Pinborg, AB & Andersen, AN 2010, 'Prospective investigation of serum anti-Müllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study', Reproductive BioMedicine Online, vol. 20, no. 5, pp. 582-7. https://doi.org/10.1016/j.rbmo.2010.02.007

APA

Freiesleben, N. L. C., Rosendahl, M., Johannsen, T. H., Løssl, K., Loft, A., Bangsbøll, S., Friis-Hansen, L., Pinborg, A. B., & Andersen, A. N. (2010). Prospective investigation of serum anti-Müllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study. Reproductive BioMedicine Online, 20(5), 582-7. https://doi.org/10.1016/j.rbmo.2010.02.007

Vancouver

Freiesleben NLC, Rosendahl M, Johannsen TH, Løssl K, Loft A, Bangsbøll S et al. Prospective investigation of serum anti-Müllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study. Reproductive BioMedicine Online. 2010 May 1;20(5):582-7. https://doi.org/10.1016/j.rbmo.2010.02.007

Author

Freiesleben, N la Cour ; Rosendahl, Mikkel ; Johannsen, Trine Holm ; Løssl, Kristine ; Loft, A ; Bangsbøll, S ; Friis-Hansen, L ; Pinborg, Anja Bisgaard ; Andersen, A Nyboe. / Prospective investigation of serum anti-Müllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study. In: Reproductive BioMedicine Online. 2010 ; Vol. 20, No. 5. pp. 582-7.

Bibtex

@article{7ff8b7a901a140179971ec5d3779a8c5,
title = "Prospective investigation of serum anti-M{\"u}llerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study",
abstract = "This preliminary prospective study investigated serum anti-M{\"u}llerian hormone (AMH) through correlations to other basal parameters (123 patients) and according to ovarian response to 75 IU recombinant follicle-stimulating hormone (rFSH)/day (62 patients) in ovulatory patients' first rFSH treatment cycle before intrauterine insemination. Mean age of the patients was 33 years. Serum AMH significantly correlated to age (r=-0.38), antral follicle count (AFC) (r=0.68), ovarian volume (r=0.40), FSH (r=-0.31), (P2-3 mature follicles or dose reduction). There was a significant trend over response groups for body weight (P=0.005), body mass index (P=0.035), AFC (P=0.031) and FSH (P=0.001). Serum AMH median (IQR) was 10.6 pmol/l (6.9-18.2) in the 23 patients who achieved an ongoing pregnancy versus 10.5 (5.9-17.2) in the 100 non-pregnant women. Serum AMH may not be the best marker of the ovarian response in these patients.",
author = "Freiesleben, {N la Cour} and Mikkel Rosendahl and Johannsen, {Trine Holm} and Kristine L{\o}ssl and A Loft and S Bangsb{\o}ll and L Friis-Hansen and Pinborg, {Anja Bisgaard} and Andersen, {A Nyboe}",
note = "Copyright (c) 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.",
year = "2010",
month = may,
day = "1",
doi = "http://dx.doi.org/10.1016/j.rbmo.2010.02.007",
language = "English",
volume = "20",
pages = "582--7",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - Prospective investigation of serum anti-Müllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study

AU - Freiesleben, N la Cour

AU - Rosendahl, Mikkel

AU - Johannsen, Trine Holm

AU - Løssl, Kristine

AU - Loft, A

AU - Bangsbøll, S

AU - Friis-Hansen, L

AU - Pinborg, Anja Bisgaard

AU - Andersen, A Nyboe

N1 - Copyright (c) 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - This preliminary prospective study investigated serum anti-Müllerian hormone (AMH) through correlations to other basal parameters (123 patients) and according to ovarian response to 75 IU recombinant follicle-stimulating hormone (rFSH)/day (62 patients) in ovulatory patients' first rFSH treatment cycle before intrauterine insemination. Mean age of the patients was 33 years. Serum AMH significantly correlated to age (r=-0.38), antral follicle count (AFC) (r=0.68), ovarian volume (r=0.40), FSH (r=-0.31), (P2-3 mature follicles or dose reduction). There was a significant trend over response groups for body weight (P=0.005), body mass index (P=0.035), AFC (P=0.031) and FSH (P=0.001). Serum AMH median (IQR) was 10.6 pmol/l (6.9-18.2) in the 23 patients who achieved an ongoing pregnancy versus 10.5 (5.9-17.2) in the 100 non-pregnant women. Serum AMH may not be the best marker of the ovarian response in these patients.

AB - This preliminary prospective study investigated serum anti-Müllerian hormone (AMH) through correlations to other basal parameters (123 patients) and according to ovarian response to 75 IU recombinant follicle-stimulating hormone (rFSH)/day (62 patients) in ovulatory patients' first rFSH treatment cycle before intrauterine insemination. Mean age of the patients was 33 years. Serum AMH significantly correlated to age (r=-0.38), antral follicle count (AFC) (r=0.68), ovarian volume (r=0.40), FSH (r=-0.31), (P2-3 mature follicles or dose reduction). There was a significant trend over response groups for body weight (P=0.005), body mass index (P=0.035), AFC (P=0.031) and FSH (P=0.001). Serum AMH median (IQR) was 10.6 pmol/l (6.9-18.2) in the 23 patients who achieved an ongoing pregnancy versus 10.5 (5.9-17.2) in the 100 non-pregnant women. Serum AMH may not be the best marker of the ovarian response in these patients.

U2 - http://dx.doi.org/10.1016/j.rbmo.2010.02.007

DO - http://dx.doi.org/10.1016/j.rbmo.2010.02.007

M3 - Journal article

VL - 20

SP - 582

EP - 587

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 5

ER -

ID: 34085065